This week, ZenPharm, the Maltese joint venture with Canadian cannabis producer, Zenabis Global, received its Maltese licence to process cannabis for medicinal use and research purposes out of its Hal Far Industrial Estate premises.
Kurt Farrugia, CEO of Malta Enterprise – the national economic development agency that assisted the company to set up locally – considers this “an important milestone for Malta’s medical cannabis industry.”
“We are gaining momentum with the production of cannabis for medical use in Malta,” he wrote. “Zenabis – a Maltese joint venture and partner of Zenpharm, have received a licence for the production of medical cannabis in their facility in Hal Far, Malta.”
The CEO said that the issuing of the second licence for the production of cannabis for medical use shows that “Malta is becoming a centre of excellence in such an important emerging sector.”
“Those companies strive hard to achieve the Medicine's Authority pharmaceutical standards. Now that they do, patients can rest assured that the Made in Malta product is top quality. A gold standard for the industry. This is indeed a proud moment.”
Through its licence, ZenPharm plans to ship around 500kg of cannabis out of Malta annually to EU countries, with the largest market being Germany.
Featured Image:
Kurt Farrugia / LinkedIn
Gianluca Borg appointed CEO of PG Group
His appointment comes shortly after the opening of the St George’s Mall.
Power cuts costing restaurants far more than spoiled food, ACE President warns
Michelle Muscat says several restuarants dealing with damaged equipment due to power cuts.
Adrian Mizzi: Building a practical transformation practice at IDEA Consulting
‘AI and digital transformation only create value when they are connected to judgement, governance and organisational learning.'
What every employer needs to know about Malta’s pay transparency law
Dr Christine Calleja, Partner at Mamo TCV Advocates, answers some of the most common questions surrounding the regulations.
